Avalyn Pharma
The Associate Director of SEC Reporting & Technical Accounting will build and lead Avalyn’s external reporting and SOX compliance capabilities as a newly public biotechnology company. This role involves establishing scalable SEC reporting processes, designing internal controls over financial reporting, and serving as the company’s subject matter expert on complex accounting matters.
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company's approach focuses on delivering inhaled formulations of established medicines directly to lung tissue to potentially enhance efficacy and reduce systemic side effects. Its pipeline includes two clinical-stage programs, AP01 (inhaled pirfenidone) and AP02 (inhaled nintedanib), as well as a preclinical program, AP03, a fixed-dose combination of both agents.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Avalyn Pharma.
Right around the average for this role
Avalyn Pharma
Aug 5, 2025
SEC Reporting Manager
Taylor Morrison
SEC Reporting Manager
Corteva Agriscience
External SEC Reporting Analyst
Corteva Agriscience
Director of SEC Reporting and Technical Accounting
Townsquare Media
Senior Manager, SEC Reporting
P.F. Chang's China Bistro, Inc.
Senior SEC Reporting Analyst
mbctalentconnections.com